Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Poveda

Showing results (71-80 of 107) with videos related to

Pageof 11
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1991
High-dose DTIC in advanced soft-tissue sarcomas in the adult. A phase II study of the E.O.R.T.C. Soft Tissue and Bone Sarcoma GroupJ M Buesa, H T Mouridsen, A T van Oosterom, et al.
Antimicrobial Agents and Chemotherapy|February 4, 2015
Experimental resistance to drug combinations in Leishmania donovani: metabolic and phenotypic adaptationsMaya Berg, Raquel García-Hernández, Bart Cuypers, et al.
Scientific Reports|April 19, 2019
Conformational plasticity in the KcsA potassium channel pore helix revealed by homo-FRET studiesM Lourdes Renart, A Marcela Giudici, José A Poveda, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 26, 2007
Treatment guidelines in ovarian cancerA Poveda Velasco, A Casado Herráez, A Cervantes Ruipérez, et al.
Biochimica Et Biophysica Acta|November 12, 2013
Lipid modulation of ion channels through specific binding sitesJ A Poveda, A M Giudici, M L Renart, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|December 15, 2010
Value of FDG-PET for monitoring treatment response in patients with advanced GIST refractory to high-dose imatinib. A multicenter GEIS studyD Fuster, J R Ayuso, A Poveda, et al.
Actas Urologicas Espanolas|January 1, 1991
[Renal arteriovenous fistula, up-date and presentation of a new case]C Domínguez Bravo, J M Soler Fernández, A Poveda Pierola, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 27, 2007
Update in the management of ovarian and cervical carcinomaA Poveda, R Salazar, J M del Campo, et al.
Applied Biochemistry and Biotechnology|September 4, 2017
Malachite Green and Crystal Violet Decolorization by Ganoderma lucidum and Pleurotus ostreatus Supernatant and by rGlLCC1 and rPOXA 1B Concentrates: Molecular Docking AnalysisEdwin D Morales-Álvarez, Claudia M Rivera-Hoyos, Sergio A Poveda-Cuevas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 1998
Phase II trial of first-line high-dose ifosfamide in advanced soft tissue sarcomas of the adult: a study of the Spanish Group for Research on Sarcomas (GEIS)J M Buesa, A López-Pousa, J Martín, et al.
Pageof 11

Showing results (71-80 of 107) with videos related to

Sort By:
Pageof 11
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1991
High-dose DTIC in advanced soft-tissue sarcomas in the adult. A phase II study of the E.O.R.T.C. Soft Tissue and Bone Sarcoma GroupJ M Buesa, H T Mouridsen, A T van Oosterom, et al.
Antimicrobial Agents and Chemotherapy|February 4, 2015
Experimental resistance to drug combinations in Leishmania donovani: metabolic and phenotypic adaptationsMaya Berg, Raquel García-Hernández, Bart Cuypers, et al.
Scientific Reports|April 19, 2019
Conformational plasticity in the KcsA potassium channel pore helix revealed by homo-FRET studiesM Lourdes Renart, A Marcela Giudici, José A Poveda, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 26, 2007
Treatment guidelines in ovarian cancerA Poveda Velasco, A Casado Herráez, A Cervantes Ruipérez, et al.
Biochimica Et Biophysica Acta|November 12, 2013
Lipid modulation of ion channels through specific binding sitesJ A Poveda, A M Giudici, M L Renart, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|December 15, 2010
Value of FDG-PET for monitoring treatment response in patients with advanced GIST refractory to high-dose imatinib. A multicenter GEIS studyD Fuster, J R Ayuso, A Poveda, et al.
Actas Urologicas Espanolas|January 1, 1991
[Renal arteriovenous fistula, up-date and presentation of a new case]C Domínguez Bravo, J M Soler Fernández, A Poveda Pierola, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 27, 2007
Update in the management of ovarian and cervical carcinomaA Poveda, R Salazar, J M del Campo, et al.
Applied Biochemistry and Biotechnology|September 4, 2017
Malachite Green and Crystal Violet Decolorization by Ganoderma lucidum and Pleurotus ostreatus Supernatant and by rGlLCC1 and rPOXA 1B Concentrates: Molecular Docking AnalysisEdwin D Morales-Álvarez, Claudia M Rivera-Hoyos, Sergio A Poveda-Cuevas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 1998
Phase II trial of first-line high-dose ifosfamide in advanced soft tissue sarcomas of the adult: a study of the Spanish Group for Research on Sarcomas (GEIS)J M Buesa, A López-Pousa, J Martín, et al.
Pageof 11